The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Direct glucocorticoid inhibition of insulin secretion. An in vitro study of dexamethasone effects in mouse islets.
Open accessAbstract
The direct effects of glucocorticoids on pancreatic beta cell function were studied with normal mouse islets. Dexamethasone inhibited insulin secretion from cultured islets in a concentration-dependent manner: maximum of approximately 75% at 250 nM and IC50 at approximately 20 nM dexamethasone. This inhibition was of slow onset (0, 20, and 40% after 1, 2, and 3 h) and only slowly reversible. It was prevented by a blocker of nuclear glucocorticoid receptors, by pertussis toxin, by a phorbol ester, and by dibutyryl cAMP, but was unaffected by an increase in the fuel content of the culture medium. Dexamethasone treatment did not affect islet cAMP levels but slightly reduced inositol phosphate formation. After 18 h of culture with or without 1 microM dexamethasone, the islets were perifused and stimulated by a rise in the glucose concentration from 3 to 15 mM. Both phases of insulin secretion were similarly decreased in dexamethasone-treated islets as compared with control islets. This inhibition could not be ascribed to a lowering of insulin stores (higher in dexamethasone-treated islets), to an alteration of glucose metabolism (glucose oxidation and NAD(P)H changes were unaffected), or to a lesser rise of cytoplasmic Ca2+ in beta cells (only the frequency of the oscillations was modified). Dexamethasone also inhibited insulin secretion induced by arginine, tolbutamide, or high K+. In this case also the inhibition was observed despite a normal rise of cytoplasmic Ca2+. In conclusion, dexamethasone inhibits insulin secretion through a genomic action in beta cells that leads to a decrease in the efficacy of cytoplasmic Ca2+ on the exocytotic process.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“by modulating insulin secretion in pancreatic beta cells ( 36-39 ),”
From Dynamic modulation of glucose utilisation by glucocorticoid rhythms in health and disease (2020) · cites this paper as [38]
In the citing paper
“In addition, animal studies8,9 have demonstrated direct inhibitory effects of GCs on insulin secretion and adverse effects on â-cell function in some human studies.10,11”
From Twenty‐four‐hour profiles of plasma glucose, insulin, C‐peptide and free fatty acid in subjects with varying degrees of glucose tolerance following short‐term, medium‐dose prednisone (20 mg/day) treatment: evidence for differing effects on insulin secretion and action (2012) · cites this paper as [8]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Berridge, M. J., Dawson, R. M. C., Downes, C. P., Heslop, J. P., & Irvine, R. F. (1983) · Biochemical Journal · doi:10.1042/bj2120473 · Cited by 1,954
Mechanism of glucose-induced insulin secretion.
Hedeskov, C. J. (1980) · Physiological Reviews · doi:10.1152/physrev.1980.60.2.442 · Cited by 435
Effects of glucocorticoids on carbohydrate metabolism
Mcmahon, M., Gerich, J., & Rizza, R. (1988) · Diabetes/Metabolism Reviews · doi:10.1002/dmr.5610040105 · Cited by 390
Moguilewsky, M., & Philibert, D. (1984) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(84)90216-4 · Cited by 371
Gembal, M., Detimary, P., Gilon, P., Gao, Z. Y., & Henquin, J. C. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116308 · Cited by 260
Self-citationGilon, P., & Henquin, J. C. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)36744-4 · Cited by 251
Self-citationD-Glucose inhibits potassium efflux from pancreatic islet cells
Henquin, J. (1978) · Nature · doi:10.1038/271271a0 · Cited by 208
Self-citationKatada, T., & Ui, M. (1979) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37941-3 · Cited by 194
Metabolic effects of the nocturnal rise in cortisol on carbohydrate metabolism in normal humans.
Dinneen, S., Alzaid, A., Miles, J., & Rizza, R. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116832 · Cited by 175
Thyroid Hormones, Gonadal and Adrenocortical Steroids and the Function of the Islets of Langerhans
Lenzen, S., & Bailey, C. J. (1984) · Endocrine Reviews · doi:10.1210/edrv-5-3-411 · Cited by 168
Flagged first, then by citations
Research works printed but not linked: 1
- Morgan, N.G., R.D. Hurst, and S.L.F. Chan. 1989. Control of insulin secretion by ␣ 2 -receptor activation. Proc. 5th Japanese ␣-receptor Conference. 79-96.
Cited by
Sorted by citations
Items 201–300 of 419
Bocca, N., Pileggi, A., Molano, R. D., Marzorati, S., Wu, W. ‐., Bodor, N. S., Ricordi, C., & Buchwald, P. (2008) · Die Pharmazie · doi:10.31083/ph.2008.7774 · Cited by 23
Cushing Syndrome, Hypercortisolism, and Glucose Homeostasis: A Review
DeFronzo, R. A., & Auchus, R. J. (2025) · Diabetes · doi:10.2337/db25-0120 · Cited by 31
Lactoferrin ameliorates corticosterone-related acute stress and hyperglycemia in rats
Maekawa, Y., Sugiyama, A., & Takeuchi, T. (2016) · Journal of Veterinary Medical Science · doi:10.1292/jvms.16-0498 · Cited by 23
Chronic hypercortisolism causes more persistent visceral adiposity than HFD-induced obesity
García-Eguren, G., Giró, O., Romero, M. D. M., Grasa, M., & Hanzu, F. A. (2019) · Journal of Endocrinology · doi:10.1530/joe-19-0168 · Cited by 27
Gloudemans, M. J., Balliu, B., Nachun, D. C., Schnurr, T. M., Durrant, M. G., Ingelsson, E., Wabitsch, M., Quertermous, T., Montgomery, S. B., Knowles, J. W., et al. (2022) · Genome Medicine · doi:10.1186/s13073-022-01036-8 · Cited by 24
Jellyman, J. K., Valenzuela, O. A., & Fowden, A. L. (2015) · Journal of Animal Science · doi:10.2527/jas.2014-8612 · Cited by 22
Rheumatoid Arthritis Treatment Options and Type 2 Diabetes: Unravelling the Association
Muzio, C. D., Cipriani, P., & Ruscitti, P. (2022) · BioDrugs · doi:10.1007/s40259-022-00561-7 · Cited by 26
Chronic Stress as a Risk Factor for Type 2 Diabetes: Endocrine, Metabolic, and Immune Implications
Lisco, G., Giagulli, V. A., Pergola, G. D., Guastamacchia, E., Jirillo, E., Vitale, E., & Triggiani, V. (2023) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/1871530323666230803095118 · Cited by 25
Kruyt, N. D., van Westerloo, D. J., & DeVries, J. H. (2012) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2011.0171 · Cited by 21
Sadhu, A., Schwartz, S. S., & Herman, M. E. (2015) · Endocrine Practice · doi:10.4158/ep14569.ra · Cited by 21
Templeman, N. M., Mehran, A. E., & Johnson, J. D. (2016) · PLoS ONE · doi:10.1371/journal.pone.0153280 · Cited by 21
G6PC2 Modulates the Effects of Dexamethasone on Fasting Blood Glucose and Glucose Tolerance
Boortz, K. A., Syring, K. E., Lee, R. A., Dai, C., Oeser, J. K., McGuinness, O. P., Wang, J.-C., & O’Brien, R. M. (2016) · Endocrinology · doi:10.1210/en.2016-1678 · Cited by 23
Portella, A. K., Silveira, P. P., Laureano, D. P., Cardoso, S., Bittencourt, V., Noschang, C. G., Werlang, I. C. R., Fontella, F. U., Dalmaz, C., & Goldani, M. Z. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.09.033 · Cited by 20
Fujimoto, S., Tsuura, Y., Ishida, H., Tsuji, K., Mukai, E., Kajikawa, M., Hamamoto, Y., Takeda, T., Yamada, Y., & Seino, Y. (2000) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2000.279.4.e927 · Cited by 20
Dissecting the Role of Glucocorticoids on Pancreas
Herrera, P. L., Duchêne, B., Czernichow, P., & Bréant, B. (2004) · Cited by 19
Rietema, S. E., Blackberry, M. A., Maloney, S. K., Martin, G. B., Hawken, P. A. R., & Blache, D. (2015) · Domestic Animal Endocrinology · doi:10.1016/j.domaniend.2015.05.005 · Cited by 22
Roma, L. P., Souza, K. L. A., Carneiro, E. M., Boschero, A. C., & Bosqueiro, J. R. (2012) · General Physiology and Biophysics · doi:10.4149/gpb_2012_011 · Cited by 19
Interactions between diabetes and COVID-19: A narrative review
Sabri, S., Bourron, O., Phan, F., & Nguyen, L. S. (2021) · World Journal of Diabetes · doi:10.4239/wjd.v12.i10.1674 · Cited by 19
Glucocorticoid receptor activation selectively influence performance of Wistar rats in Y-maze
Abdulbasit, A., Michael, F. S., Onaopemipo, A. S., Abdulmusawwir, A.-O., Aminu, I., Tobechukwu, A. N., Imam, A. W., Adeyanju, O. A., Olaseinde, F., Aderonke, A. B., et al. (2017) · Pathophysiology · doi:10.1016/j.pathophys.2017.12.002 · Cited by 18
Xu, W., Cui, J., Zhou, F., Bai, M., Deng, R., & Wang, W. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.05.184 · Cited by 18
Kim, K., KANG, Y. Y., Choi, S., Kim, J. H., Kim, H. M., Sun, B., Jun, H., & Yoon, J. (2002) · Diabetes · doi:10.2337/diabetes.51.9.2764 · Cited by 18
Pretty, C. G. (2012) · UC Research Repository (University of Canterbury) · doi:10.26021/2015 · Cited by 18
Wintergerst, K. A., Foster, M. B., Sullivan, J. E., & Woods, C. R. (2012) · Journal of Diabetes Science and Technology · doi:10.1177/193229681200600102 · Cited by 17
Hyperglycemia in Patients with Hematologic Malignancies
Healy, S. J., & Dungan, K. M. (2015) · Current Diabetes Reports · doi:10.1007/s11892-015-0581-x · Cited by 16
The obesity-associated transcription factor ETV5 modulates circulating glucocorticoids
Gutiérrez‐Aguilar, R., Thompson, A. K., Marchand, N., Dumont, P., Woods, S. C., de Launoit, Y., Seeley, R. J., & Ulrich‐Lai, Y. M. (2015) · Physiology & Behavior · doi:10.1016/j.physbeh.2015.03.027 · Cited by 16
Prevention and management of transplant-associated diabetes
Jenssen, T. G., & Hartmann, A. (2011) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2011.628936 · Cited by 16
Ranta, F., Düfer, M., Stork, B., Wesselborg, S., Drews, G., Häring, H., Lang, F. J. W., & Ullrich, S. (2008) · Cellular Signalling · doi:10.1016/j.cellsig.2008.06.003 · Cited by 16
Nagaraju, R., & Rajini, P. S. (2016) · Pesticide Biochemistry and Physiology · doi:10.1016/j.pestbp.2016.04.009 · Cited by 17
Glukokortikoidinduzierte Insulinresistenz und Diabetes mellitus
Meyer, G., & Badenhoop, K. W. J. (2003) · Medizinische Klinik - Intensivmedizin und Notfallmedizin · doi:10.1007/s00063-003-1255-z · Cited by 16
Scanes, C. G., Pierzchała, K., & Gajewska, A. (2024) · Animals · doi:10.3390/ani14050752 · Cited by 15
A genetic mouse model of lean-NAFLD unveils sexual dimorphism in the liver-heart axis
Burelle, C., Clapatiuc, V., Deschênes, S., Cuillerier, A., Loof, M. D., Higgins, M., Boël, H., Daneault, C., Chouinard, B., Clavet‐Lanthier, M., et al. (2024) · Communications Biology · doi:10.1038/s42003-024-06035-6 · Cited by 15
Glycyrrhizic Acid Improves Lipid and Glucose Metabolism in High-Sucrose-Fed Rats
Chandramouli, C., Yong, S. T., Lam, Y. L., Ton, S. H., & Kadir, K. A. (2011) · Journal of Endocrinology and Metabolism · doi:10.4021/jem.v1i3.39 · Cited by 15
Delangre, E., Liu, J., Tolu, S., Maouche, K., Armanet, M., Cattan, P., Pommier, G., Bailbé, D., & Movassat, J. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-04419-8 · Cited by 15
The mechanisms by which antidepressants may reduce coronary heart disease risk
Mathews, M. J., Mathews, E. H., & Liebenberg, L. (2015) · BMC Cardiovascular Disorders · doi:10.1186/s12872-015-0074-5 · Cited by 15
Dalle, S., & Abderrahmani, A. (2024) · Cells · doi:10.3390/cells13151244 · Cited by 15
The phase of the estrous cycle modifies the endocrine, metabolic and behavior rhythms in ewes
Pinto-Santini, L., & Ungerfeld, R. (2019) · Physiology & Behavior · doi:10.1016/j.physbeh.2019.03.011 · Cited by 14
Kluwe, B., Ortiz, R., Odei, J. B., Zhao, S., Kline, D., Brock, G. N., Echouffo-Tcheugui, J. B., Lee, J., Lazarus, S. A., Seeman, T. E., et al. (2020) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2020.105041 · Cited by 14
Insulin resistance as a risk factor for subclinical atherosclerosis in rheumatoid arthritis
Sayed, A. M. E., Bakry, S. A. E., Mobasher, S., Rahman, R. A. E., Abo‐Shady, R. A., & Abaza, N. (2013) · The Egyptian Rheumatologist · doi:10.1016/j.ejr.2013.08.003 · Cited by 14
Daimon, M., KAMBA, A., Murakami, H., Mizushiri, S., Osonoi, S., Matsuki, K., Sato, E., Tanabe, J., Takayasu, S., Matsuhashi, Y., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-10815-y · Cited by 14
Tanaka, K., Okada, Y., Mori, H., Torimoto, K., Arao, T., & Tanaka, Y. (2017) · Internal Medicine · doi:10.2169/internalmedicine.9013-17 · Cited by 14
Glucocorticoids Inhibit Basal and Hormone-Induced Serotonin Synthesis in Pancreatic Beta Cells
Ebou, M. H., Singh‐Estivalet, A., Launay, J., Callebert, J., Tronche, F., Ferré, P., Gautier, J., Guillemain, G., Bréant, B., Blondeau, B., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0149343 · Cited by 15
Antenatal dexamethasone and the growth hormone–insulin-like growth factor axis
Ogueh, O., MIELL, J. P., Jones, J. C., Jones, J., Alaghband‐Zadeh, J., & Johnson, M. R. (2000) · Human Reproduction · doi:10.1093/humrep/15.6.1403 · Cited by 14
Yue, L., Li, J., Yao, M., Song, S., Zhang, X., & Wang, Y. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1455691 · Cited by 14
Acclimation and Blood Sampling: Effects on Stress Markers in C57Bl/6J Mice
Marin, N., Moragon, A. C., Gil-Casanova, D., Garcia‐García, F., & Bisbal, V. (2023) · Animals · doi:10.3390/ani13182816 · Cited by 13
Medical treatment of Cushing’s disease with concurrent diabetes mellitus
Mehlich, A., Bolanowski, M., Mehlich, D., & Witek, P. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1174119 · Cited by 13
Ionita, I. A., Ogasawara, K., Gohh, R., & Akhlaghi, F. (2014) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0000000000000045 · Cited by 13
Acetylation of Hsp90 reverses dexamethasone-mediated inhibition of insulin secretion
Zhu, K., Zhang, Y., Zhang, J., Zhou, F., Zhang, L., Wang, S., Zhu, Q., Liu, Q., Wang, X., & Zhou, L. (2019) · Toxicology Letters · doi:10.1016/j.toxlet.2019.11.022 · Cited by 13
Miceli, D., Gallelli, M., Blatter, M. F. C., Martiarena, B., Brañas, M., Ortemberg, L., Gómez, N., & Castillo, V. (2012) · Research in Veterinary Science · doi:10.1016/j.rvsc.2011.07.003 · Cited by 16
Metabolic and hormonal responses to subcutaneous glucagon in healthy beagles
Zeugswetter, F. K., Schornsteiner, E., Haimel, G., & Schwendenwein, I. (2012) · Journal of Veterinary Emergency and Critical Care · doi:10.1111/j.1476-4431.2012.00793.x · Cited by 13
Type 2 diabetes mellitus and the cardiometabolic syndrome: impact of incretin-based therapies
Schwartz, S. S. (2010) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmsott.s11389 · Cited by 16
Liu, Y., Havinga, R., Bloks, V. W., Baller, J., van der Leij, F. R., Reijngoud, D., Sauer, P. J. J., & Kuipers, F. (2007) · Pediatric Research · doi:10.1203/pdr.0b013e31802d89ff · Cited by 13
Cortisol secretion and abnormalities of glucose metabolism in nondiabetic patients with hypertension
Brosolo, G., Porto, A. D., Bulfone, L., Vacca, A., Bertin, N., Catena, C., & Sechi, L. A. (2023) · Journal of Hypertension · doi:10.1097/hjh.0000000000003590 · Cited by 12
The Effect of Curative Treatment on Hyperglycemia in Patients With Cushing Syndrome
Herndon, J. S., Kaur, R. J., Romportl, M., Smith, E., Koenigs, A., Partlow, B. J., Arteaga, L., & Bancos, I. (2021) · Journal of the Endocrine Society · doi:10.1210/jendso/bvab169 · Cited by 13
Kim, J., Park, Y.-K., KIM, J.-E., Lee, S., Kim, B.-C., & Jang, B. (2013) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2013.1364 · Cited by 12
Shah, M. A., Haris, M. N., Faheem, H. I., Hamid, A., Yousaf, R., Rasul, A., Shah, G. M., Khalil, A. A. K., Wahab, A., Khan, H. Z., et al. (2022) · Current Pharmaceutical Design · doi:10.2174/1381612828666220628123224 · Cited by 13
Arumugam, R., Fleenor, D., & Freemark, M. (2007) · Endocrine · doi:10.1007/s12020-007-9017-y · Cited by 12
Glucococorticoid-Induced Death of Pancreatic Beta Cells: An Organized Chaos
Rojas, J., Chávez-Castillo, M., Chávez-Castillo, M., Cabrera, M., Cabrera, M., Bermúdez, V., & Bermúdez, V. (2015) · PubMed · doi:10.6092/1590-8577/2893 · Cited by 12
Kim, J., Sun, C., Jeon, S., You, Y., Shin, J., Lee, S., Cho, J., Park, C., & Yoon, K. (2012) · BMB Reports · doi:10.5483/bmbrep.2012.45.1.51 · Cited by 12
Burke, S. J., May, A. L., Noland, R. C., Lu, D., Briššová, M., Powers, A. C., Sherrill, E. M., Karlstad, M. D., Campagna, S. R., Stephens, J. M., et al. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.632190 · Cited by 12
A novel highly potent and selective 11β-hydroxysteroid dehydrogenase type 1 inhibitor, UI-1499
Byun, S. Y., Shin, Y. J., Nam, K.-Y., Hong, S. P., & Ahn, S. K. (2014) · Life Sciences · doi:10.1016/j.lfs.2014.11.001 · Cited by 11
Song, Y., Margolles‐Clark, E., Fraker, C. A., Weaver, J. D., Ricordi, C., Pileggi, A., Stabler, C. L., & Buchwald, P. (2012) · Die Pharmazie · doi:10.31083/ph.2012.1697 · Cited by 11
Barrosa, K. H., Mecchi, M. C., Rando, D. G. G., Ferreira, A. J. S., Sartorelli, P., Valle, M. M. R., Bordin, S. A., Caperuto, L. C., Lago, J. H. G., & Lellis‐Santos, C. (2016) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2016.09.013 · Cited by 11
Guarnotta, V., Emanuele, F., Salzillo, R., Bonsangue, M., Amato, C., Mineo, M. I., & Giordano, C. S. D. S. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1248985 · Cited by 11
Xie, X., Wang, X., Mick, G. J., Kabarowski, J. H. S., Wilson, L. S., Barnes, S., Walcott, G. P., Luo, X., & McCormick, K. L. (2016) · Endocrinology · doi:10.1210/en.2015-1831 · Cited by 11
Diabète et corticoïdes : nouveautés et aspects pratiques
Bastin, M., & Andréelli, F. (2020) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2020.05.007 · Cited by 11
Rafacho, A., Antonio, C., & Ortsäter, H. (2012) · InTech eBooks · doi:10.5772/50233 · Cited by 12
Kim, J.-W., Park, S., You, Y., Ham, D., Park, H., Lee, S., Yang, H. K., & Yoon, K. (2014) · Transplantation · doi:10.1097/01.tp.0000438627.68225.25 · Cited by 11
Karagiannopoulos, A., Westholm, E., Ofori, J. K., Cowan, E., Esguerra, J. L. S., & Eliasson, L. (2023) · iScience · doi:10.1016/j.isci.2023.106555 · Cited by 10
β-Cell-Specific Glucocorticoid Reactivation Attenuates Inflammatory β-Cell Destruction
Liu, X., Turban, S., Carter, R. N., Ahmad, S., Ramage, L. E., Webster, S. P., Walker, B. R., Seckl, J. R., & Morton, N. M. (2014) · Frontiers in Endocrinology · doi:10.3389/fendo.2014.00165 · Cited by 10
Wang, X., Heinrich, D. A., Kunz, S. L., Heger, N., Sturm, L., Uhl, O., Beuschlein, F., Reincke, M., & Bidlingmaier, M. (2021) · Scientific Reports · doi:10.1038/s41598-021-90901-4 · Cited by 10
Shah, M., Adel, M., Tahsin, B., Guerra, Y., & Fogelfeld, L. (2020) · PLoS ONE · doi:10.1371/journal.pone.0231190 · Cited by 7
Effect of Dexamethasone on Insulin Secretion: Examination of Underlying Mechanisms
Sood, A., & Ismail‐Beigi, F. (2010) · Endocrine Practice · doi:10.4158/ep09372.or · Cited by 11
Glucocorticoid receptor-NECAB1 axis can negatively regulate insulin secretion in pancreatic β-cells
Udagawa, H., Funahashi, N., Nishimura, W., Uebanso, T., Kawaguchi, M., ASAHI, R., Nakajima, S., Nammo, T., Hiramoto, M., & Yasuda, K. (2023) · Scientific Reports · doi:10.1038/s41598-023-44324-y · Cited by 9
Gorący, I., Gorący, J., Safranow, K., Skonieczna‐Żydecka, K., & Ciechanowicz, A. (2012) · Archives of Medical Research · doi:10.1016/j.arcmed.2012.10.020 · Cited by 9
Diabetes in stiff-person syndrome
Heneberg, P. (2023) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2023.07.005 · Cited by 9
Improved Human Islet Preparations Using Glucocorticoid and Exendin-4
Miki, A., Ricordi, C., Yamamoto, T., Sakuma, Y., Misawa, R., Mita, A., Inverardi, L., Alejandro, R., & Ichii, H. (2014) · Pancreas · doi:10.1097/mpa.0000000000000184 · Cited by 9
Finlay, C. J., Argoud, K., Wilder, S. P., Ouali, F., Ktorza, A., Kaisaki, P. J., & Gauguier, D. (2010) · Mammalian Genome · doi:10.1007/s00335-010-9285-3 · Cited by 9
Ahire, Y., Gandhi, S., Ghaisas, M. M., Dandawate, P. R., & Mule, M. (2011) · Indian Journal of Pharmaceutical Sciences · doi:10.4103/0250-474x.100232 · Cited by 9
Roohk, D. J., Mascharak, S., Khambatta, C. F., Leung, H., Hellerstein, M. K., & Harris, C. A. (2013) · Endocrinology · doi:10.1210/en.2011-1047 · Cited by 9
Sensitivity of the Neuroendocrine Stress Axis in Metabolic Diseases
Cozma, D., Siatra, P., Bornstein, S. R., & Steenblock, C. (2024) · Hormone and Metabolic Research · doi:10.1055/a-2201-6641 · Cited by 9
The role of macrophage migration inhibitory factor in obesity-associated type 2 diabetes in mice
Saksida, T., Stošić‐Grujičić, S., & Stojanović, I. (2013) · Archives of Biological Sciences · doi:10.2298/abs1302499s · Cited by 9
Beta-Cell Dysfunction and Insulin Resistance after Subarachnoid Haemorrhage
Kruyt, N., Musters, A., Biessels, G., DeVries, J., Coert, B., Vergouwen, M., Horn, J., & Roos, Y. B. (2011) · Neuroendocrinology · doi:10.1159/000324097 · Cited by 10
Longer HSD11B2 CA-repeat in impaired glucose tolerance and type 2 diabetes
Mune, T., Suwa, T., Morita, H., Isomura, Y., Takada, N., Yamamoto, Y., Hayashi, M., Yamakita, N., Sasaki, A., Takeda, N., et al. (2013) · Endocrine Journal · doi:10.1507/endocrj.ej12-0108 · Cited by 9
Glicocorticóides e síndrome metabólica: aspectos favoráveis do exercício físico nesta patofisiologia
Pauli, J. R., Souza, L. S., Rogatto, G. P., Gomes, R., & Luciano, E. (2006) · Revista Portuguesa de Ciências do Desporto · doi:10.5628/rpcd.06.02.217 · Cited by 10
Dynamic modulation of glucose utilisation by glucocorticoid rhythms in health and disease
Zavala, E., Gil-Gómez, C. A., Wedgwood, K. C. A., Burgess, R., Tsaneva-Atanasova, K., & Herrera-Valdez, M. A. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.02.27.968354 · Cited by 8
Lam, S.-H., Liu, H., Chung, S.-Y., Chang, J., Hong, M.-X., Kuo, S., & Liaw, C. (2023) · Journal of Natural Products · doi:10.1021/acs.jnatprod.3c00114 · Cited by 8
Lithium treatment mitigates the diabetogenic effects of chronic cortico-therapy
Delangre, E., Pommier, G., Tolu, S., Uzan, B., Bailbé, D., & Movassat, J. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114895 · Cited by 9
Adaptive genetic variation, stress and glucose regulation
Oriel, R. C., Wiley, C. D., Dewey, M. J., & Vrana, P. B. (2008) · Disease Models & Mechanisms · doi:10.1242/dmm.000661 · Cited by 9
Binayi, F., Zardooz, H., Ghasemi, R., Hedayati, M., Askari, S., Pouriran, R., & Sahraei, M. (2021) · Physiology & Behavior · doi:10.1016/j.physbeh.2021.113312 · Cited by 8
Kloster‐Jensen, K., Sahraoui, A., Vethe, N. T., Korsgren, O., Bergan, S., Foss, A. E., & Scholz, H. (2016) · Journal of Diabetes Research · doi:10.1155/2016/4196460 · Cited by 8
Roussel, M., Mathieu, J., & Dalle, S. (2016) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2015-0071 · Cited by 8
Kim, G., Yoo, M., Hong, M. H., Lee, B., Kang, E. S., Soo, B., Kim, H. R., Lee, Y., & Cho, B. C. (2019) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-019-03889-0 · Cited by 8
Glucocorticoids and glucolipotoxicity alter the DNA methylome and function of human EndoC-βH1 cells
dos Santos, C., Karagiannopoulos, A., Rafacho, A., Perfilyev, A., Eliasson, L., Ling, C., & Bacos, K. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120854 · Cited by 7
Gagliardi, L., & Jeunne, C. L. (2012) · La Presse Médicale · doi:10.1016/j.lpm.2012.01.008 · Cited by 7
Yang, X., Lin, X., Lu, T., Chen, P., Wang, X., & Hou, F. F. (2015) · American Journal of Nephrology · doi:10.1159/000377642 · Cited by 7
Pathophysiology of critical illness hyperglycemia in children
Hacıhamdioğlu, B., Kendirli, T., Öçal, G., Şıklar, Z., Erdeve, Ş. S., İnce, E., & Berberoğlu, M. (2013) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2012-0313 · Cited by 7
New-onset diabetes after transplantation
Pavlakis, M. (2005) · Current Diabetes Reports · doi:10.1007/s11892-005-0027-y · Cited by 7
Brix, J. M., Tura, A., Herz, C. T., Feder, A., Krzizek, E.-C., Parzer, V., Pacini, G., & Ludvik, B. H. (2021) · Obesity Facts · doi:10.1159/000517766 · Cited by 6
Pan, M., Yang, G., Cui, X., & Yang, S.-N. (2010) · Experimental Diabetes Research · doi:10.1155/2011/604989 · Cited by 6
Metadata
- Authors
- Lambillotte, C., Gilon, P., & Henquin, J. C.
- Affiliations
- UCLouvain (BE)
- ORCID
- Gilon, P
- Venue
- Journal of Clinical Investigation
- Published
- 1997-02-01
- Volume
- 99
- Issue
- 3
- Pages
- 414-423
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC507814
- OpenAlex
- W2047680032
- Cited by
- 419
- References
- 59
- Citations by year
- 2026: 3 · 2025: 13 · 2024: 9 · 2023: 14 · 2022: 9 · 2021: 18 · 2020: 13 · 2019: 17 · 2018: 9 · 2017: 10 · 2016: 17 · 2015: 27 · 2014: 26 · 2013: 23 · 2012: 30
- FWCI
- 4.99
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Digital Access to Libraries (Université catholique de Louvain (UCL), l'Université de Namur (UNamur) and the Université Saint-Louis (USL-B)) (submittedVersion, other-oa)
- Funders
- Fédération Wallonie-Bruxelles
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Keywords
- dexamethasone, glucocorticoids, insulin secretion, pancreatic beta cells, pancreatic islets, glucocorticoid receptor, pertussis toxin, phorbol ester, cyclic AMP, inositol phosphates, intracellular calcium, exocytosis, glucose-stimulated insulin secretion, L-arginine, tolbutamide, high potassium stimulation, glucose metabolism
- MeSH terms
- Insulin Secretion, Cyclic AMP, Animals, Arginine, B-Lymphocytes, Calcium, Cells, Cultured, Dexamethasone, Bucladesine, Dose-Response Relationship, Drug, Glucocorticoids, Glucose, Inositol Phosphates, Insulin, Islets of Langerhans, Male, Mice, Inbred Strains, NADP, Oxidation-Reduction, Virulence Factors, Bordetella, Phorbol Esters, Potassium, Receptors, Glucocorticoid, Tolbutamide, Pertussis Toxin, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review